purchase customization

1 Study Coverage
1.1 Mental Disorders Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Mental Disorders Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Drugs for Schizophrenia
1.2.3 Antidepressants
1.2.4 Antipsychotics
1.2.5 Anxiolytics
1.2.6 Drugs for the Treatment of Substance and Alcohol Addiction
1.2.7 Drugs for Childhood and Adolescent Mental Illness
1.2.8 Drugs to Treat Cognitive Disorders
1.2.9 Sleep Disorders
1.2.10 Others
1.3 Market by Application
1.3.1 Global Mental Disorders Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Children
1.3.3 Adolescents
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mental Disorders Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Mental Disorders Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Mental Disorders Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Mental Disorders Drugs Sales by Region
2.4.1 Global Mental Disorders Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Mental Disorders Drugs by Region (2023-2028)
2.5 Global Mental Disorders Drugs Revenue by Region
2.5.1 Global Mental Disorders Drugs Revenue by Region (2017-2022)
2.5.2 Global Mental Disorders Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Mental Disorders Drugs Sales by Manufacturers
3.1.1 Global Top Mental Disorders Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Mental Disorders Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Mental Disorders Drugs in 2021
3.2 Global Mental Disorders Drugs Revenue by Manufacturers
3.2.1 Global Mental Disorders Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Mental Disorders Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Mental Disorders Drugs Revenue in 2021
3.3 Global Mental Disorders Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mental Disorders Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Mental Disorders Drugs Sales by Type
4.1.1 Global Mental Disorders Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Mental Disorders Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Mental Disorders Drugs Sales Market Share by Type (2017-2028)
4.2 Global Mental Disorders Drugs Revenue by Type
4.2.1 Global Mental Disorders Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Mental Disorders Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Mental Disorders Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Mental Disorders Drugs Price by Type
4.3.1 Global Mental Disorders Drugs Price by Type (2017-2022)
4.3.2 Global Mental Disorders Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Mental Disorders Drugs Sales by Application
5.1.1 Global Mental Disorders Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Mental Disorders Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Mental Disorders Drugs Sales Market Share by Application (2017-2028)
5.2 Global Mental Disorders Drugs Revenue by Application
5.2.1 Global Mental Disorders Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Mental Disorders Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Mental Disorders Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Mental Disorders Drugs Price by Application
5.3.1 Global Mental Disorders Drugs Price by Application (2017-2022)
5.3.2 Global Mental Disorders Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Mental Disorders Drugs Market Size by Type
6.1.1 North America Mental Disorders Drugs Sales by Type (2017-2028)
6.1.2 North America Mental Disorders Drugs Revenue by Type (2017-2028)
6.2 North America Mental Disorders Drugs Market Size by Application
6.2.1 North America Mental Disorders Drugs Sales by Application (2017-2028)
6.2.2 North America Mental Disorders Drugs Revenue by Application (2017-2028)
6.3 North America Mental Disorders Drugs Market Size by Country
6.3.1 North America Mental Disorders Drugs Sales by Country (2017-2028)
6.3.2 North America Mental Disorders Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Mental Disorders Drugs Market Size by Type
7.1.1 Europe Mental Disorders Drugs Sales by Type (2017-2028)
7.1.2 Europe Mental Disorders Drugs Revenue by Type (2017-2028)
7.2 Europe Mental Disorders Drugs Market Size by Application
7.2.1 Europe Mental Disorders Drugs Sales by Application (2017-2028)
7.2.2 Europe Mental Disorders Drugs Revenue by Application (2017-2028)
7.3 Europe Mental Disorders Drugs Market Size by Country
7.3.1 Europe Mental Disorders Drugs Sales by Country (2017-2028)
7.3.2 Europe Mental Disorders Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Mental Disorders Drugs Market Size by Type
8.1.1 Asia Pacific Mental Disorders Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Mental Disorders Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Mental Disorders Drugs Market Size by Application
8.2.1 Asia Pacific Mental Disorders Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Mental Disorders Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Mental Disorders Drugs Market Size by Region
8.3.1 Asia Pacific Mental Disorders Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Mental Disorders Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Mental Disorders Drugs Market Size by Type
9.1.1 Latin America Mental Disorders Drugs Sales by Type (2017-2028)
9.1.2 Latin America Mental Disorders Drugs Revenue by Type (2017-2028)
9.2 Latin America Mental Disorders Drugs Market Size by Application
9.2.1 Latin America Mental Disorders Drugs Sales by Application (2017-2028)
9.2.2 Latin America Mental Disorders Drugs Revenue by Application (2017-2028)
9.3 Latin America Mental Disorders Drugs Market Size by Country
9.3.1 Latin America Mental Disorders Drugs Sales by Country (2017-2028)
9.3.2 Latin America Mental Disorders Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Mental Disorders Drugs Market Size by Type
10.1.1 Middle East and Africa Mental Disorders Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Mental Disorders Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Mental Disorders Drugs Market Size by Application
10.2.1 Middle East and Africa Mental Disorders Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Mental Disorders Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Mental Disorders Drugs Market Size by Country
10.3.1 Middle East and Africa Mental Disorders Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Mental Disorders Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Overview
11.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Johnson & Johnson Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Johnson & Johnson Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 AstraZeneca Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bristol-Myers Squibb Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Laboratories Mental Disorders Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Mental Disorders Drugs Industry Chain Analysis
12.2 Mental Disorders Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mental Disorders Drugs Production Mode & Process
12.4 Mental Disorders Drugs Sales and Marketing
12.4.1 Mental Disorders Drugs Sales Channels
12.4.2 Mental Disorders Drugs Distributors
12.5 Mental Disorders Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mental Disorders Drugs Industry Trends
13.2 Mental Disorders Drugs Market Drivers
13.3 Mental Disorders Drugs Market Challenges
13.4 Mental Disorders Drugs Market Restraints
14 Key Findings in The Global Mental Disorders Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer